General Information
Revision date
2018-10-17
Product name
Sumatriptan succinate
Substance name
Sumatriptan succinate
Chemical name
[3-[2Dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide
CAS No.
103628-48-4
supplier name
Duchefa Farma BV
Emergency telephone
Supplier contact information
Icons in SDS
Company Information
company name
Duchefa Farma BV
e-mail address of the competent person responsible for the Safety Data Sheet
farma@duchefa.nl
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H334, H361
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
CLP CLASSIFICATION
Classification according to Regulation (EC) No. 1272/2008 [CLP]Show]] CLP information only Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Reproductive toxicity, Category 2 H361
Hazard statements
see section 16 : H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H361 - Suspected of damaging fertility or the unborn child.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP] Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS08
Signal word
Danger
Precautionary statements
P261 - Avoid breathing dust. P302+P352 - IF ON SKIN: Wash with plenty of water/… P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305 - IF IN EYES: P351 - Rinse cautiously with water for several minutes. P308+P313 - IF exposed or concerned: Get medical advice.
2.3 Other hazards
No additional information available
